Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Evoke Spinal Cord Stimulation (SCS) System.
- Who it may be relevant to
- Registry conditions: Chronic Pain. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Australia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Prospective, Multicentre, Single-arm Feasibility Study Examining Novel Treatment Delivery of the Evoke Spinal Cord Stimulator (SCS) System to Treat Patients With Chronic Pain of the Trunk and/or Limbs
Overview
The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.
Interventions
- Device Evoke Spinal Cord Stimulation (SCS) System
ECAP-controlled, closed-loop SCS
Primary outcome measures
- Change in Evoke Compound Action Potentials (ECAPs) as measured by the Evoke SCS System [Time frame: Through study completion, up to 2 years]
Eligibility criteria
Inclusion criteria
- 1\. Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication.
- 2\. Subject is willing and capable of giving informed consent and able to comply with study-related requirements.
Exclusion criteria
N/A
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Australia · 25 centers
- ACT Pain Centre — Garran
- Sydney Pain Specialists — Bella Vista
- Genesis Research Services — Broadmeadow
- Northern Integrated Pain Management — Charlestown
- Australian Medical Research — Hurstville
- Inner West Pain Centre — Newtown
- Royal North Shore Hospital — Saint Leonards
- Northern Pain Centre — St Leonards
- … and 17 more centers
Publications
- Parker DJ, Antony AB, Smith GL, Goree JH, Russo MA, Petersen EA, Vu CM, Verrills P, Gilmore C, Kapural L, Nanavati D, Karantonis DM, Pope JE. Next-Generation SCS Programming Platform: Enhancing ECAP Fidelity and Objectivity to Improve Patient Experience. Pain Ther. 2026 Apr;15(2):465-480. doi: 10.1007/s40122-025-00808-5. Epub 2026 Jan 8. PMID 41505067
Identifiers
NCT: NCT04662905 · CLIN-PCL-007873